Orviva

Learn · Variants · ABCG8

rs11887534 ABCG8

ABCG8 D19H homozygous. Significantly increased gallstone risk (2-3x).

Curated · human-reviewed Health risk · Risk / effect allele: C · dbSNP

What is rs11887534?

rs11887534 is a single-nucleotide polymorphism (SNP) in the ABCG8 gene (ATP-binding cassette subfamily G member 8). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as CC. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs11887534 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
CChighABCG8 D19H homozygous. Significantly increased gallstone risk (2-3x).88%
CG / GCelevatedABCG8 D19H carrier. Increased gallstone risk.85%
GGtypical / lowerTypical gallstone risk.88%

How common is the C allele of rs11887534?

Minor-allele frequency by population (gnomAD / 1000 Genomes):

European11.0%
East Asian1.0%
African1.0%
South Asian4.0%
Admixed American6.0%
Global5.0%

Which drugs have annotations for rs11887534?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
atorvastatinEfficacy3
simvastatinEfficacy3

Is rs11887534 on 23andMe and AncestryDNA chips?

Yes — it is genotyped directly on 23andMe V3, 23andMe V4, 23andMe V5, AncestryDNA V1, AncestryDNA V2. Orviva reads it from a raw-data export without imputation.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.